Common Contracts
2 similar Security Agreement contracts by Molecular Insight Pharmaceuticals, Inc.
EX-10.2 3 dex102.htm SECURITY AGREEMENT BETWEEN MOLECULAR INSIGHT PHARMACEUTICALS, INC. AND NEXBANK Executed Version SECURITY AGREEMENTSecurity Agreement • May 5th, 2020 • New York
SECURITY AGREEMENT, dated as of April 28, 2011, made by Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the “Grantor”), in favor of NexBank SSB, a Texas-chartered savings bank (“NexBank”), as collateral agent (in such capacity, together with its successors and assigns in such capacity, the “Collateral Agent”) acting pursuant to this Agreement for the benefit of the Secured Parties (as defined in the Credit Agreement referred to below).
SECURITY AGREEMENTSecurity Agreement • May 4th, 2011 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
SECURITY AGREEMENT, dated as of April 28, 2011, made by Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the “Grantor”), in favor of NexBank SSB, a Texas-chartered savings bank (“NexBank”), as collateral agent (in such capacity, together with its successors and assigns in such capacity, the “Collateral Agent”) acting pursuant to this Agreement for the benefit of the Secured Parties (as defined in the Credit Agreement referred to below).
